Optimal Designs for Estimating the ED50 When Response Functions Have a Downturn

Research output: Contribution to journalArticle

Abstract

The is the dose which, on average, produces 50% of the maximum possible response. In many cases, dose-response functions have a downturn at higher doses. If researchers ignore the downturn and try to select doses below the peak dose, there is some loss of information. This study analyzes the loss of information and changes in optimal designs for estimating the due to restricting the dose range. We assume that responses are continuous and doses to be used are restricted to be between some fixed minimum and maximum doses. For biologically motivated models that incorporate a downturn in the response function, c-optimal designs for estimating the and the c-optimal designs using the restricted dose range are obtained and compared. This article also presents a two-stage optimal design for estimating the that is not substantially affected by restricting the dose range.

Original languageEnglish (US)
Pages (from-to)9-15
Number of pages7
JournalStatistics in Biopharmaceutical Research
Volume6
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Response Function
Dose
Research Personnel
Range of data
Two-stage Design
Dose-response

Keywords

  • Dose Range
  • Experimental Design
  • Peak Dose
  • c-Optimality

ASJC Scopus subject areas

  • Statistics and Probability
  • Pharmaceutical Science

Cite this

Optimal Designs for Estimating the ED50 When Response Functions Have a Downturn. / Hyun, Seung Won.

In: Statistics in Biopharmaceutical Research, Vol. 6, No. 1, 01.01.2014, p. 9-15.

Research output: Contribution to journalArticle

@article{53320c911dfa4eb294e12fcc309ee4a8,
title = "Optimal Designs for Estimating the ED50 When Response Functions Have a Downturn",
abstract = "The is the dose which, on average, produces 50{\%} of the maximum possible response. In many cases, dose-response functions have a downturn at higher doses. If researchers ignore the downturn and try to select doses below the peak dose, there is some loss of information. This study analyzes the loss of information and changes in optimal designs for estimating the due to restricting the dose range. We assume that responses are continuous and doses to be used are restricted to be between some fixed minimum and maximum doses. For biologically motivated models that incorporate a downturn in the response function, c-optimal designs for estimating the and the c-optimal designs using the restricted dose range are obtained and compared. This article also presents a two-stage optimal design for estimating the that is not substantially affected by restricting the dose range.",
keywords = "Dose Range, Experimental Design, Peak Dose, c-Optimality",
author = "Hyun, {Seung Won}",
year = "2014",
month = "1",
day = "1",
doi = "10.1080/19466315.2013.823887",
language = "English (US)",
volume = "6",
pages = "9--15",
journal = "Statistics in Biopharmaceutical Research",
issn = "1946-6315",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Optimal Designs for Estimating the ED50 When Response Functions Have a Downturn

AU - Hyun, Seung Won

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The is the dose which, on average, produces 50% of the maximum possible response. In many cases, dose-response functions have a downturn at higher doses. If researchers ignore the downturn and try to select doses below the peak dose, there is some loss of information. This study analyzes the loss of information and changes in optimal designs for estimating the due to restricting the dose range. We assume that responses are continuous and doses to be used are restricted to be between some fixed minimum and maximum doses. For biologically motivated models that incorporate a downturn in the response function, c-optimal designs for estimating the and the c-optimal designs using the restricted dose range are obtained and compared. This article also presents a two-stage optimal design for estimating the that is not substantially affected by restricting the dose range.

AB - The is the dose which, on average, produces 50% of the maximum possible response. In many cases, dose-response functions have a downturn at higher doses. If researchers ignore the downturn and try to select doses below the peak dose, there is some loss of information. This study analyzes the loss of information and changes in optimal designs for estimating the due to restricting the dose range. We assume that responses are continuous and doses to be used are restricted to be between some fixed minimum and maximum doses. For biologically motivated models that incorporate a downturn in the response function, c-optimal designs for estimating the and the c-optimal designs using the restricted dose range are obtained and compared. This article also presents a two-stage optimal design for estimating the that is not substantially affected by restricting the dose range.

KW - Dose Range

KW - Experimental Design

KW - Peak Dose

KW - c-Optimality

UR - http://www.scopus.com/inward/record.url?scp=84893950447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893950447&partnerID=8YFLogxK

U2 - 10.1080/19466315.2013.823887

DO - 10.1080/19466315.2013.823887

M3 - Article

VL - 6

SP - 9

EP - 15

JO - Statistics in Biopharmaceutical Research

JF - Statistics in Biopharmaceutical Research

SN - 1946-6315

IS - 1

ER -